Jacob Wekalao | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Mr. Jacob Wekalao | Cancer Cell Biology | Best Researcher Award

Mr. Jacob Wekalao , USTC CHINA , China

Jacob Wekalao is a Physics professional and researcher with extensive experience in both academia and industry. He holds a Doctor of Philosophy from the University of Science and Technology and a Master of Science in Physics from Marwadi University, India. Jacob has worked as a physics teacher, leading the physics department at Kwale High School, Kenya, and is currently a software expert at Eujim Solutions, where he specializes in creating innovative business solutions. He is also a Research Assistant at Marwadi University, contributing to advanced research in physics and nanotechnology. His expertise spans across terahertz sensors, graphene-based biosensors, and surface plasmon resonance techniques. In addition to his academic endeavors, Jacob has authored several peer-reviewed publications, showcasing his contributions to forensic science, health, and biomedical applications. Jacob is passionate about research, mentoring, and leveraging technology to solve real-world problems.

Publication Profile:

Orcid

Strengths for the Award:

Jacob Wekalao is an exceptional researcher in the field of experimental physics, particularly in the areas of nanotechnology, terahertz sensors, and biosensing. His work integrates cutting-edge research with practical applications, demonstrating a high level of innovation and expertise. Jacob’s contributions to the development of graphene-based sensors for various applications, including healthcare, forensic science, and security, have positioned him as a thought leader in his field. His published works in prestigious journals and his active role in research projects, such as designing biosensors for early disease detection, highlight his proficiency in both theoretical and applied physics. Additionally, Jacob’s ability to collaborate internationally and present at major conferences reflects his commitment to advancing scientific knowledge and networking within the global research community.

Areas for Improvement:

While Jacob excels in his research and technological expertise, expanding his focus on interdisciplinary collaborations could further elevate his work. Engaging more with industry experts in areas like artificial intelligence or machine learning could also open doors for more transformative innovations, especially in optimizing sensor technologies. Further involvement in policy or public science initiatives could help bridge the gap between research and broader societal applications.

Education:

Jacob Wekalao has an impressive educational background that supports his expertise in physics and technology. He is currently pursuing a Doctor of Philosophy at the University of Science and Technology, China. His academic journey began with a Bachelor of Education in Science with a focus on Physics and Mathematics from the University of Embu, Kenya (2016-2020). This solid foundation propelled him to obtain a Master of Science in Physics from Marwadi University, Rajkot, Gujarat, India (2021-2023). During his time at Marwadi University, Jacob excelled academically, earning an Academic Gold Medal in November 2023 for his outstanding performance. His commitment to learning is also reflected in certifications from institutions like KAIST and the Israel Institute of Technology. Jacob’s education is characterized by a blend of theoretical knowledge and practical skills, which has enabled him to contribute significantly to the fields of experimental physics and applied technology.

Experience:

Jacob Wekalao has diverse experience spanning education, research, and industry. From September 2019 to August 2021, he worked as a Physics teacher at Kwale High School, Kenya, where he led the physics department, developed curriculum materials, and managed science projects. This role enabled him to foster critical thinking and scientific inquiry among students. In addition to his teaching experience, Jacob is currently employed as a Software Expert at Eujim Solutions, Kenya (July 2023 – Present), where he provides tailored software solutions, improves business efficiency, and implements cutting-edge technologies. Furthermore, he works as a Research Assistant at Marwadi University, collaborating on various physics research projects focused on terahertz sensors and biosensors. His involvement in multiple projects and publications has established him as a valuable contributor to advancements in technology and scientific research. Jacob’s work showcases a seamless integration of theoretical physics and practical application in technology.

Awards and Honors:

Jacob Wekalao’s dedication to academic excellence and research has earned him notable awards and honors. He received the prestigious Academic Gold Medal from Marwadi University, Rajkot, India, in November 2023, recognizing his exceptional performance in the Master of Science in Physics program. Jacob’s achievements are further validated by his numerous peer-reviewed publications, which have contributed to the global scientific community. His research in the fields of biosensing, terahertz technology, and nanomaterials has earned him recognition at various international platforms. In addition to academic awards, Jacob’s work has been presented at leading conferences, such as the International Conference on Chemical Safety and Security for Health and Environment (ICCSSHE), held in India in December 2023. His strong academic performance, leadership in research, and contributions to technological advancements continue to set him apart as an outstanding professional in his field.

Research Focus:

Jacob Wekalao’s research focuses on experimental physics, particularly in the areas of terahertz technology, biosensing, and nanomaterials. His work has significant implications for applications in healthcare, security, and forensic science. Jacob has developed and optimized graphene-based terahertz surface plasmon resonance sensors for the detection of various biomolecules, including hemoglobin and illicit drugs. His research has extended to the design of graphene metasurfaces for efficient detection of diseases like malaria and COVID-19. Jacob’s research in biosensors has led to highly sensitive, cost-effective solutions that hold promise for point-of-care diagnostics and environmental monitoring. Additionally, his work on the use of metasurfaces for explosive detection has practical implications for security. Through his research, Jacob combines advanced theoretical physics with real-world applications, contributing to the fields of biomedical technology, environmental monitoring, and security. His interest in machine learning also aids in optimizing these sensor technologies for better precision and performance.

Publications Top Notes:

  1. “Graphene-based THz surface plasmon resonance biosensor for hemoglobin detection applicable in forensic science.” 📖🔬
  2. “Design of ring and cross-shaped graphene metasurface sensor for efficient detection of malaria and 2-bit encoding applications.” 🦠🔍
  3. “Waterborne bacteria detecting highly sensitive graphene metasurface-based cost-efficient and efficient refractive index sensors.” 💧🔬
  4. “Design of graphene metasurface sensor for efficient detection of COVID-19.” 🦠💡
  5. “Graphene biosensor design based on glass substrate for forensic detection of illicit drugs.” 💊🔍
  6. “Graphene and Gold Metasurface-Based Terahertz Surface Plasmon Resonance Sensor for Explosive Detection.” 💥🛡️
  7. “Terahertz Optical Ultrasensitive Glucose Detection Using Graphene and Silver Surface Plasmon Resonance Metasurfaces for Biomedical Applications.” 🩺🔬
  8. “High-Sensitivity Graphene-Gold Metasurface Optical Biosensor for Early Melanoma Detection Optimized with Machine Learning Using a One-Dimensional Convolutional Neural Network and Binary Encoding.” 🧬🔬

Conclusion:

Jacob Wekalao’s contributions to the fields of physics and technology demonstrate an impressive combination of academic excellence, hands-on expertise, and innovative solutions. His drive to advance scientific knowledge and apply it for real-world impact, especially in healthcare and security, makes him a deserving candidate for the Best Researcher Award. Jacob’s ongoing work on high-sensitivity biosensors and his ability to stay ahead of technological trends make him a standout researcher in his field.

 

 

 

Peter du Plessis | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Mr. Peter du Plessis | Cancer Cell Biology | Best Researcher Award

Mr. Peter du Plessis , iThemba LABS , South Africa

Peter Clark du Plessis is an accomplished professional with a robust background in radiotherapy and oncology. His career spans over two decades, starting as a Radiation Therapist and Researcher at iThemba LABS since 2006. He is dedicated to both teaching and research, fostering critical thinking and academic growth among students. Apart from his academic contributions, Peter is passionate about mentoring and enjoys long walks and playing chess in his spare time. With a string of accolades, including Director’s Special Awards in 2012 and 2014, he consistently demonstrates excellence in his field. He is committed to inspiring the next generation of healthcare professionals through hands-on experience, leadership, and a deep passion for his profession.

Publication Profile:

Orcid

Strengths for the Award:

Peter Clark du Plessis exemplifies the qualities of a leading researcher in radiotherapy and oncology, making him highly suitable for the Best Researcher Award. His career spans over two decades, showcasing not only professional expertise but a commitment to advancing cancer treatment through research. Peter has a wealth of hands-on experience, holding key roles at iThemba LABS, where his research continues to shape the field of hypofractionated radiotherapy for breast and prostate cancers. His mentorship and dedication to teaching further highlight his influence on future healthcare professionals. Additionally, his accolades, including two Director’s Special Awards, demonstrate a history of excellence and recognition from peers in his field. Peter’s work also bridges research and practice, contributing significantly to improving radiotherapy techniques for cancer patients.

Areas for Improvement:

Although Peter’s achievements are commendable, his research could benefit from increased international collaborations to diversify research perspectives and data. Further partnerships with global research institutions could strengthen the practical impact of his findings, particularly in addressing diverse patient needs in different populations. Expanding his visibility in clinical trials and engaging with other healthcare sectors could further solidify his standing as a leader in oncology research.

Education (150 words):

Peter Clark du Plessis is currently pursuing a Doctorate in Radiography (DRRAD) at the Durban University of Technology, focusing on the hypofractionated radiotherapy for breast and prostate cancer (2022-2024). He holds a Master’s degree in Radiography from the Cape Peninsula University of Technology (2017-2018), with research on radiosensitivity variations in breast cancer cells. Peter earned his Bachelor of Technology in Radiography (cum laude) in 2010 and a National Diploma in Therapeutic Radiography in 1997, both from Cape Peninsula Technikon. Additionally, he began studying Computer Science at the University of the Western Cape but did not complete the degree. His academic journey highlights his passion for improving patient care and advancing cancer treatment techniques, including his research on proton beam therapies. Peter’s ongoing research aligns with his deep commitment to enhancing oncology practices through both theoretical and practical contributions.

Experience (150 words):

Peter has a comprehensive professional history, notably as a Radiation Therapist and Researcher at iThemba LABS since 2006. Here, he has been at the forefront of advancements in radiation therapy and oncology research. Prior to that, he held positions at the Provincial Hospital in Port Elizabeth as Chief Radiation Therapist (2006) and at King Abdul-Aziz Medical City as a Mould Room Technician and Radiation Therapist (2003-2005). His teaching experience is equally impressive, having served as a lecturer and moderator at Cape Peninsula University of Technology and North West University since 2019. He has contributed to health science research courses, specifically focusing on data analysis, publications, and radiation therapy practice. His multifaceted roles in both academic and clinical settings have honed his skills in education, research, and professional development. Peter’s work has had a significant impact on radiotherapy practices and student education, particularly in the field of cancer treatment.

Awards and Honors (150 words):

Peter Clark du Plessis has received multiple awards, demonstrating his dedication and excellence in the field of radiotherapy. Most notably, he was honored with two Director’s Special Awards at iThemba LABS in 2012 and 2014, recognizing his outstanding contributions to research and clinical advancements in radiation therapy. These accolades affirm his deep commitment to both research and the application of radiotherapy techniques, specifically in cancer treatment. His work in radiotherapy has helped bridge theoretical knowledge with real-world practice, particularly in advanced cancer therapies like proton beam treatments. Peter’s passion for the field and ability to integrate research with clinical practices has been acknowledged throughout his career, making him a key figure in advancing healthcare practices. His recognition reflects the impact of his research and teaching on future healthcare professionals in the radiation therapy domain.

Research Focus (150 words):

Peter Clark du Plessis focuses on exploring and advancing radiotherapy techniques, particularly in the context of hypofractionated radiotherapy for breast and prostate cancer. His research delves into the efficacy and molecular mechanisms of these treatments, especially using proton beam therapy. With a strong foundation in radiobiology, his work investigates the variation in radiosensitivity between different cancer and normal cell types, with a particular interest in breast cancer. Peter’s research aims to improve patient outcomes by refining radiotherapy protocols, making cancer treatment more effective and personalized. His contributions are significant in bridging the gap between laboratory research and clinical practices. Peter’s goal is to inspire new approaches in cancer care by combining in vitro studies with clinical observations. His ongoing work at iThemba LABS and various academic institutions positions him at the forefront of research into innovative radiotherapy solutions.

Publications (Titles with Emojis):

  • Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights 🧑‍🔬📚
  • In Vitro Perspective on Hypofractionated Radiotherapy in Breast Cancer 🧑‍🔬📚
  • Immunological Changes During Space Travel: A Ground-Based Evaluation of the Impact of Neutron Dose Rate on Plasma Cytokine Levels in Human Whole Blood Cultures 🌌💉
  • The Impact of Dose Rate on DNA Double-Strand Break Formation and Repair in Human Lymphocytes Exposed to Fast Neutron Irradiation 🧬⚛️

Conclusion:

Peter Clark du Plessis is a remarkable candidate for the Best Researcher Award due to his extensive experience, impressive body of research, and dedication to advancing radiotherapy practices. His work continues to impact the field of oncology positively, offering new insights into cancer treatment methodologies. With continued growth in research collaboration and global outreach, Peter is poised to further enhance his contributions to the field of radiotherapy.

 

 

 

Arunima Biswas | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Arunima Biswas | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Arunima Biswas , university of kalyani , India

Dr. Arunima Biswas is an Assistant Professor in the Department of Zoology at the University of Kalyani, India. With a Ph.D. in Biochemistry from the Indian Institute of Chemical Biology, Kolkata, she has focused her career on understanding the molecular mechanisms underlying diseases, particularly cancer and parasitic infections. She leads multiple funded research projects, aiming to develop targeted therapies for various cancers. Dr. Biswas has worked extensively on the cyclic nucleotide signaling pathways in unicellular eukaryotes like Leishmania and cancer. A passionate educator and researcher, she mentors Ph.D. students and collaborates with international scientists to advance medical research.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Arunima Biswas demonstrates significant contributions to cancer research and parasitology. She is highly skilled in understanding and manipulating cyclic nucleotide signaling pathways, which play a crucial role in cancer biology and parasitic diseases like Leishmania infections. With several ongoing research projects, including the repurposing of phosphodiesterase inhibitors for cancer therapy and the development of targeted drug delivery systems, Dr. Biswas has shown an innovative approach to solving complex medical challenges. Her leadership as Principal Investigator for high-impact projects, such as cancer screening and drug targeting, highlights her as a leading researcher in her field. Furthermore, her dedication to mentoring and producing highly qualified Ph.D. students is commendable.

Areas for Improvement:

While Dr. Biswas’ research is already impactful, expanding her work on the practical clinical application of her findings could further bridge the gap between research and patient care. Collaboration with clinical trials or hospitals could expedite the translation of her findings into therapeutic solutions. Additionally, expanding interdisciplinary collaborations could bring novel insights into her research.

Education:

Dr. Arunima Biswas earned her Ph.D. in Biochemistry from the Indian Institute of Chemical Biology, Kolkata, with a thesis on Host-parasite interaction: Modulation of signaling pathways in Macrophage and Leishmania (2010). Prior to this, she completed her Master of Science in Zoology from the University of Calcutta with First Class honors (2005). She also holds a Bachelor of Science in Zoology from Maulana Azad College, University of Calcutta (2003). Her academic journey has been marked by a strong foundation in biochemistry, signaling pathways, and parasitology, forming the basis of her current research interests.

Experience:

Dr. Arunima Biswas has over a decade of teaching and research experience. As an Assistant Professor at the University of Kalyani, she has significantly contributed to the academic and research growth in the Department of Zoology. She is the Principal Investigator of several research projects funded by national bodies like CSIR, SERB, and UGC, with an emphasis on cancer research, especially targeting pathways involving cyclic nucleotides. Dr. Biswas has also collaborated with multiple national and international institutions and mentored several Ph.D. students, contributing to their academic and research advancements. Her experience in guiding research and mentoring future scientists is widely acknowledged.

Awards and Honors:

Dr. Arunima Biswas has received numerous accolades for her research and academic contributions. Notably, she won the Young Scientist Presentation Award at the Translational Cancer Research Conference (2020) and was honored with an International Congress of Cell Biology Travel Award (2016). She also received the American Society of Biochemistry and Cell Biology Travel Award (2015) and the prestigious DST-INSPIRE Faculty Scheme award (2012). These recognitions underscore her outstanding contributions to biomedical research, particularly in cancer biology and parasitology, further establishing her as a leader in her field.

Research Focus:

Dr. Arunima Biswas’s research focuses on cancer biology and parasitology, particularly the role of cyclic nucleotide signaling in cancer and Leishmania infections. She investigates therapeutic targets to modulate these pathways for better treatment options in cancer, including breast and gynecological cancers. Her ongoing projects include exploring phosphodiesterase inhibitors for breast cancer and cervical cancer, as well as developing vesicular drug carriers for targeted drug delivery. Dr. Biswas is dedicated to understanding the molecular intricacies of host-parasite interactions and their implications for disease management.

Publications Top Notes:

  1. Metal Oxide–Enhanced Para-Coumaric Acid Nanoparticles for Precision Targeting of Leishmania donovani
  2. Repurposing Approved Protein Kinase Inhibitors as Potent Anti-Leishmanials Targeting Leishmania MAP Kinases
  3. Anticancer, Antimicrobial, and Photocatalytic Activities of a New Pyrazole-Containing Thiosemicarbazone Ligand and Its Co(III) and Ni(II) Complexes
  4. Synthesis, Spectroscopy, and Structural Elucidation of Two New CoII and NiII Complexes of Pyrazole Derived Heterocyclic Schiff Base Ligand as Potential Anticancer and Photocatalytic Agents
  5. Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity
  6. Rhodamine Hydrazide-Linked Naphthalimide Derivative: Selective Naked Eye Detection of Cu2+, S2− and Understanding the Therapeutic Potential of the Copper Complex as an Anti-Cervical Cancer Agent
  7. Modulation and Determination of the Status of Inflammasomes in Leishmania-Infected Macrophages
  8. Catalytic and Anticancer Activity of Two New Ni(II) Complexes with a Pyrazole-Based Heterocyclic Schiff-Base Ligand
  9. Biophysical Study on DNA and BSA Binding Activity of Cu(II) Complex: Synthesis, Molecular Docking, Cytotoxic Activity, and Theoretical Approach
  10. Cytotoxic Behavior and DNA/BSA Binding Activity of Thiosemicarbazone-Based Ni(II) Complex: Bio-Physical, Molecular Docking, and DFT Study

Conclusion:

Dr. Arunima Biswas is an exceptional candidate for the “Best Researcher Award.” Her diverse research in cancer biology, parasitology, and drug development showcases her commitment to advancing healthcare. She has made significant strides in understanding complex molecular mechanisms, and her work holds great promise for improving cancer treatments. With a robust academic record, influential publications, and ongoing impactful projects, Dr. Biswas is undoubtedly a deserving contender for the award.

 

 

 

Ayrton Bangolo | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Ayrton Bangolo | Cancer Cell Biology | Best Researcher Award

Dr. Ayrton Bangolo , Hackensack University Medical Center , United States

Ayrton I. Bangolo, MD, is an accomplished board-certified Internal Medicine physician specializing in Hematology and Oncology. He completed his MBBS (equivalent to MD) from Tianjin Medical University, China, in 2016 and is currently a Hematology and Oncology fellow at Hackensack University Medical Center, NJ. With an impressive record of research publications and contributions to several medical journals, he has a passion for advancing cancer care and the clinical aspects of various diseases. Dr. Bangolo is deeply involved in both clinical practice and research, having worked in multiple specialties and international medical settings. His expertise is enriched by his diverse experiences across different clinical environments, from hospitals in the United States to clinics in the Democratic Republic of the Congo. He holds a variety of leadership roles, demonstrating commitment to the global advancement of healthcare.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Ayrton I. Bangolo’s exceptional contributions to the medical field make him a strong candidate for the “Best Researcher Award.” His work spans critical areas of oncology, including the impact of tumor stage and histopathology on survival outcomes in esophageal cancer, as well as his pioneering research on the gut microbiome’s role in pancreatic cancer treatment. His academic rigor is evident through his prolific research output and successful collaboration with international researchers. Additionally, Dr. Bangolo’s role as a peer reviewer for prominent medical journals underscores his expertise and respect in the medical community. His focus on racial, ethnic, and socioeconomic disparities in cancer care reflects his commitment to improving healthcare outcomes for underserved populations. Moreover, his ongoing research aims to bridge knowledge gaps in critical areas such as thyroid cancer management and gastrointestinal malignancies.

Areas for Improvement:

While Dr. Bangolo’s work is impressive, expanding his collaborative efforts to include more interdisciplinary research could enhance his scope even further. Although his focus on cancer disparities is commendable, there may be opportunities to expand his research into other areas of healthcare equity, such as mental health in cancer patients or global access to cancer treatments. Additionally, increasing involvement in clinical trials may provide real-world validation for his findings, leading to more practical applications in patient care.

Education:

Dr. Bangolo obtained his MBBS from Tianjin Medical University, Tianjin, China, in 2016, and has earned multiple certifications in the United States, including the ECFMG certification. He has successfully completed the USMLE exams, passing all steps (1, 2, and 3) on the first attempt. Dr. Bangolo is currently undergoing advanced training in Hematology and Oncology at Hackensack University Medical Center, NJ, in an ACGME-accredited fellowship program. His prior residency in Internal Medicine and a transitional year at Palisades Medical Center, North Bergen, NJ, has further honed his skills. Throughout his education, Dr. Bangolo has consistently demonstrated academic excellence and a commitment to evidence-based practice. His journey through diverse healthcare systems and international medical education reflects his dedication to global health improvement and patient-centered care.

Experience:

Dr. Bangolo has extensive clinical experience spanning multiple specialties, beginning with his externship and observership roles in Endocrinology, Nephrology, and Interventional Radiology. He served at Endocrine Associates in Louisville, KY, and worked with Dr. Hisham Alrefai in Endocrinology and Dr. Mohammed El Kheir in Nephrology. His residency in Internal Medicine at Palisades Medical Center, North Bergen, NJ, allowed him to build foundational skills in patient care and management across various medical conditions. Currently, he is completing an ACGME-accredited fellowship in Hematology and Oncology at Hackensack University Medical Center, where he continues to refine his expertise in treating complex cancer patients. Additionally, Dr. Bangolo has contributed to clinical research and presented at various academic conferences. His exposure to diverse medical environments, from the US to the Democratic Republic of the Congo, gives him a well-rounded perspective on healthcare delivery.

Awards and Honors:

Dr. Bangolo has received numerous awards and accolades, highlighting his outstanding contributions to the medical field. Among his notable recognitions is the 2nd Place for his original research poster on “Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery Performed” during the HMH North Region Fellow/Residents Research Day. He was also involved in publishing open-access articles on significant public health issues, including the United Nations Sustainable Development Goals related to cancer treatment disparities. Dr. Bangolo’s work on ultrasound performance in the diagnosis of thyroid cancer earned recognition in the scientific community. His publications have made significant impacts, including in journals such as Breast Cancer Research and Treatment and World Journal of Gastroenterology. His consistent dedication to advancing medical knowledge, addressing healthcare disparities, and improving treatment outcomes has made him a respected figure in his field.

Research Focus:

Dr. Bangolo’s research primarily focuses on oncology, with a particular emphasis on cancer disparities, treatment outcomes, and innovative diagnostic methods. He has extensively studied the impacts of tumor stage and histopathology on survival outcomes in esophageal cancer and the influence of primary percutaneous coronary intervention on myocardial infarction outcomes. His work also includes investigating trends in thyroid cancer incidence, improving the understanding of gastrointestinal cancers, and exploring the role of the microbiome in pancreatic cancer. Dr. Bangolo is dedicated to researching the epidemiological factors that influence cancer outcomes in underserved populations, with a particular interest in racial, ethnic, and socioeconomic differences in treatment and survival. His ongoing research aims to improve treatment protocols and contribute to global cancer care, especially in resource-limited settings like the Democratic Republic of the Congo, where he has firsthand experience working.

Publications Top Notes:

  1. The Impact of Tumor Stage and Histopathology on Survival Outcomes in Esophageal Cancer Patients 📑
  2. Comprehensive Analysis of the Impact of Primary Percutaneous Coronary Intervention on Patients with ST-Segment Elevation Myocardial Infarction 💓
  3. Impact of American Thyroid Association’s Revised Cancer Management Guidelines on Thyroid Cancer Incidence Trends 📊
  4. Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery Performed and Delayed Surgical Treatment 🎗️
  5. Ultrasound Performance Using the EU-TIRADS Score in the Diagnosis of Thyroid Cancer 🩺
  6. Epidemiologic Risk Factors for Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma 🦠
  7. Impact of Gut Microbiome in the Development and Treatment of Pancreatic Cancer 🧬
  8. Primary Cardiac Sarcoma: Clinical Characteristics and Prognostic Factors ❤️
  9. The Overall Quality of Evidence of Recommendations Surrounding Nutrition and Diet in Inflammatory Bowel Disease 🥗
  10. Outcomes of Patients with Gastrointestinal Stromal Tumors in the Past Decade 💉

Conclusion:

Dr. Ayrton I. Bangolo is undoubtedly a leading researcher in the field of oncology, with a robust academic and clinical background, significant contributions to medical literature, and a passion for addressing global healthcare disparities. His dedication to understanding complex diseases, combined with his focus on improving patient outcomes, positions him as a deserving candidate for the “Best Researcher Award.” Expanding his research to incorporate broader interdisciplinary efforts and clinical trials would further elevate his impact.

 

 

 

Vidhant Nambiar | Cancer Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Vidhant Nambiar | Cancer Cell Biology | Best Researcher Award

Dr. Vidhant Nambiar , Fiji National University , Fiji

Dr. [Name] is currently the Acting Head of the Department of Dental Public Health, Paediatrics, and Preventive Dentistry at Fiji National University (FNU). With expertise in public health and dental care, Dr. [Name] is dedicated to improving oral health and public health across Fiji and the Pacific region. Actively involved in academic and clinical research, Dr. [Name] is the Chair of the FNU School of Dentistry and Oral Health’s Research Committee and a member of the Oral Health Pacific Island Alliance (OPIA) and the International Association of Dental Research (IADR). In addition to teaching undergraduate and postgraduate dental students, Dr. [Name] supervises research in areas like oral cancer and the effects of heat-treated cooking oils. A committed researcher and educator, Dr. [Name] also contributes to global oral health advocacy through international collaborations and presentations.

Publication Profile:

Orcid

Strengths for the Award:

  1. Innovative Research Focus: The study “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji” addresses a critical gap in oral health research, specifically the link between environmental carcinogens and oral cancer, an issue of high relevance in Fiji and the broader Pacific region.
  2. Strong Academic Foundation: The researcher holds a Master of Science in Public Health and a Bachelor of Dental Surgery with notable academic achievements. Their award-winning background and practical clinical experience underscore their ability to handle complex research.
  3. Ongoing, High-Impact Research: The study is in a randomized controlled trial phase, demonstrating rigor and potential for publication in high-impact journals. The trial also received seed funding, which reflects its importance to the broader public health community.
  4. Multidisciplinary Expertise: The researcher brings a blend of public health, clinical dentistry, and research skills to the project, offering a holistic approach to understanding health risks in the Pacific Island context.

Areas for Improvements:

  1. Expanded Collaboration: To maximize the impact of the research, future work could involve more international collaborations or partnerships with other universities or research institutes, enhancing the study’s global reach and significance.
  2. Greater Focus on Data Analysis: While the research is promising, further attention to advanced statistical analyses and more diverse data sources could provide even more robust conclusions.
  3. Wider Community Engagement: Increasing community-based research engagement and ensuring that findings are shared with local populations in accessible formats could further strengthen public health responses.

Education:

Dr. [Name] holds a Master of Science in Public Health from the University of South Wales (2021), equipping them with advanced knowledge of public health principles and practices. Prior to that, Dr. [Name] earned a Bachelor of Dental Surgery from Fiji National University (FNU), where they received the prestigious Pierre Fauchard Award in 2017. During their academic journey, Dr. [Name] gained extensive hands-on clinical experience and was exposed to cutting-edge dental technology and modern practices, including through an elective project at Melbourne and La Trobe University in 2017. This solid academic background, paired with practical dental experience, laid the foundation for their commitment to advancing oral health education, research, and policy development.

Experience:

Dr. [Name] has an extensive career in dental public health and clinical practice. As the Acting Head of the Department of Dental Public Health, Paediatrics, and Preventive Dentistry at FNU, Dr. [Name] oversees curriculum development, academic program delivery, and research activities. They have led multiple community outreach initiatives and have a demonstrated ability to manage strategic planning and research projects. Dr. [Name] has also served as a Lecturer in Dental Public Health, teaching courses across various undergraduate levels and guiding students in their research endeavors. Previous roles include managing the oral surgery clinic at CWM Hospital, where they treated complex surgical cases and participated in surgical audits. Dr. [Name] has also been integral in the COVID-19 response efforts, providing support at the Valelevu Fever Clinic and contributing to public health initiatives aimed at controlling the pandemic.

Research Focus:

Dr. [Name]’s research primarily focuses on oral health and public health, with a particular emphasis on the impact of environmental factors on oral health. Currently, they are conducting a randomized controlled trial titled “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji,” which has qualified for seed funding and is pending publication. This research aims to examine the links between oral cancer and the consumption of oils that have been repeatedly heated, a pressing issue in Pacific Island communities. Dr. [Name] is also a supervisor for research projects related to dental technology, community dentistry, and oral health prevention. Additionally, they have contributed to research on tobacco and betel nut chewing habits, publishing findings in the International Journal of Advanced Research. Their research not only aims to improve clinical practice but also has a broader public health impact, focusing on improving prevention strategies and health outcomes.

Publication Top Notes:

  • “Tobacco and Betel Nut Chewing Habits Amongst Fijians of Indian Descent Living in Suva, Fiji” 📚
  • “Analysis of Genotoxic Oral Cancer Carcinogens in Repeatedly Heated Cooking Oils in Suva, Fiji” 🔬

Conclusion:

This researcher demonstrates strong potential for the Best Researcher Award due to their innovative approach to a significant public health issue. Their current research on genotoxic carcinogens in heated cooking oils addresses an underexplored area of oral cancer prevention and risk factors, particularly in Fiji. With a solid academic background and practical experience, the researcher is well-positioned to make significant contributions to the field. Expanding collaborations, enhancing data analysis, and engaging more directly with communities could further amplify the impact of their work.